Chemical synthesis method and use method of ergothioneine

Through the four-step chemical synthesis method, the production process of ergothionine is simplified, the existing methods have solved the problems of numerous steps and high cost, and the efficient production of ergothionine of pure optical isomers or mixtures is achieved, which is suitable for industrialization application.

CN119032084APending Publication Date: 2024-11-26NANJING NUTRABUILDING BIO TECH CO LTD
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202280094935.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2022-04-22
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

The existing chemical synthesis methods of ergothionine are numerous, costly, and it is difficult to effectively produce non-natural enantiomer D-ergothionine.

Method used

Four-step chemical synthesis method is adopted: histidine reacts with protective reagents in the presence of alkali, then reacts with alkylating reagents, then hydrolyzes in the presence of acids, and reacts with halogenating reagents and vulcanizing reagents, and finally obtains ergosulphur through cleavage Because it is possible to produce pure optical isomers or mixtures in any proportion thereof.

Benefits of technology

The synthesis steps are simplified, yields are improved, costs are reduced, and can be economically and conveniently used in industrial production of ergothionine, providing high-quality ergothionine, including mixtures of its L- and D-forms.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005086381690000031
    Figure BDA0005086381690000031
  • Figure BDA0005086381690000033
    Figure BDA0005086381690000033
  • Figure BDA0005086381690000035
    Figure BDA0005086381690000035
Patent Text Reader

Abstract

The invention provides a chemical synthesis method of ergothioneine in different optical forms (such as L-form or D-form or any mixture thereof). Another aspect of the invention relates to a composition comprising a non-racemic mixture of L-ergothioneine and D-ergothioneine.
Need to check novelty before this filing date? Find Prior Art

Description

Background Art

[0001] Ergothioneine (EGT) was discovered by Charles Tanret in 1909 while studying the ergot fungus, Claviceps purpurea. It is a naturally occurring sulfur-containing amino acid that is known to be synthesized only by non-yeast fungi and certain bacteria. Although it cannot be synthesized by humans, ergothioneine is present throughout the human body, with highest concentrations in the kidneys, liver, red blood cells, and semen. While some functions remain to be elucidated, ergothioneine may be important for human health due to the ubiquity of a specific transporter in many tissues (Journal of Functional Foods, Vol. 77, February 2021, 104326). Studies have highlighted its antioxidant capacity in vitro, as well as its possible cytoprotective capacity in vivo (Scientific Reports, Vol. 8, Article No. 1601 (2018)). Since humans cannot synthesize ergothioneine, it can only be obtained through diet. Studies in animals and humans have found no toxicity or adverse effects from ergothioneine administration, even at high doses, and ergothioneine (Tetrahedron, Paris, France) has recently been approved by the European Food Safety Authority in the European Union and is generally recognized as a safe supplement by the Food and Drug Administration in the United States (GRAS Notice No. 734) (FEBS Letters 592 (2018) 3357–3366).

[0002] Therefore, ergothioneine is a potentially useful dietary supplement. The current method for preparing ergothioneine includes extraction from natural sources, biosynthetic pathways and chemical synthesis, such as Chinese patent CN 106831597B discloses a method for preparing ergothioneine from mushrooms; U.S. Patents 10,544,437B2 and 10,167,490B2 disclose a biosynthetic method of ergothioneine; and U.S. Patents 5,438,151A, 7,767,826B2, 8,399,500B2, 9,908,854B2 and 9,428,463B1 disclose a chemical synthesis method of ergothioneine.

[0003] The invention provides a chemical synthesis method of thioneine. Interestingly, by using this method, non-natural enantiomer D-thioneine can also be easily obtained from D-histidine. Therefore, depending on the selection of the starting compound, each component of the composition can be a pure optical isomer (for example, L-form or D-form), or a mixture of two isomers, and the starting compound can exist in pure L-form or D-form, or exist as its mixture. In addition, this method greatly reduces the total number of the synthesis steps for preparing EGT, and improves total yield, thereby reducing cost. In addition, the method disclosed in the present application can also be economically and conveniently used for the industrial production of thioneine. Summary of the invention

[0004] This Summary is provided to introduce some concepts in a simplified form that are further described below in the Detailed Description. This Summary is not intended to identify key features or essential features of the claimed subject matter, nor is it intended to be used to limit the scope of the claimed subject matter.

[0005] One aspect of the present invention provides a novel method for chemically synthesizing different optical isomers of ergothioneine or its physiologically acceptable salt, comprising the following consecutive steps: (a) in a first solvent, in the presence of a base, reacting histidine (compound (I)) with a protecting agent I and a protecting agent II to obtain compound (II), wherein the histidine is in L-form, D-form or a mixture of L- and D-forms in any ratio; (b) reacting compound (II) with an alkylating agent in a second solvent to obtain compound (III); (c) hydrolyzing compound (III) in a third solvent in the presence of an acid to obtain compound (IV); (d) in a fourth solvent, compound (IV) is reacted with a halogenating agent, then with a sulfurizing agent selected from L-cysteine, (D,L)-cysteine ​​and D-cysteine, and then with a cleavage agent, After the post-treatment process, ergothioneine (compound (V)) is obtained; The ergothionein obtained is in the L-form, the D-form or a mixture of the L-form and the D-form in any ratio.

[0006] In some embodiments, compound (II) has the following structure: Examples of R include

[0007] In some embodiments, compound (III) has the following structure: Examples of R include

[0008] In some embodiments, compound (IV) has the following structure:

[0009] In some embodiments, compound (V) has the following structure:

[0010] In some embodiments, in step (a), Protecting agent 1 is selected from dimethyldichlorosilane, trimethylchlorosilane and dichlorodiphenylsilane; Protecting agent 2 is selected from triphenylmethane chloride, diphenylmethane chloride and benzyl bromide; The first solvent is selected from the group consisting of dichloromethane, tetrahydrofuran and chloroform; and The base is selected from pyridine, N,N-diisopropylethylamine and triethylamine.

[0011] In some preferred embodiments, in step (a), protecting agent 1 is dimethyldichlorosilane, protecting agent 2 is triphenylmethane chloride, the first solvent is dichloromethane, and the base is triethylamine or pyridine.

[0012] In some embodiments, in step (a), the molar ratio of the base to compound (I) ranges from 1:1 to 3:1; the molar ratio of the protecting agent 1 to compound (I) ranges from 1:1 to 3:1; the molar ratio of the protecting agent 2 to compound (I) ranges from 1:1 to 3:1; and the reaction temperature ranges from 0-80°C, more preferably from 10-40°C.

[0013] In some embodiments, in step (b), the alkylating agent is selected from dimethyl sulfate, methyl iodide, methyl bromide, or methyl chloride; and the second solvent is selected from acetonitrile, methanol, ethanol, or water.

[0014] Preferably, in step (b), the alkylating agent is dimethyl sulfate and the second solvent is methanol.

[0015] In some embodiments, in step (b), the molar ratio of the alkylating agent to compound (II) ranges from 1:1 to 3:1; and the reaction temperature ranges from 20 to 100°C, more preferably 20-30°C.

[0016] In some embodiments, in step (c), the third solvent is selected from acetonitrile, methanol, ethanol or water; and the acid is selected from hydrochloric acid, sulfuric acid, trifluoroacetic acid or trifluoromethanesulfonic acid.

[0017] Preferably, in step (c), the third solvent is water, and the acid is hydrochloric acid.

[0018] In some embodiments, in step (c), the molar ratio of acid to compound (III) ranges from 1:1 to 10:1, preferably 2:1 to 5:1; and the reaction temperature ranges from 20 to 80°C, or preferably 70-80°C.

[0019] In some embodiments, in step (d), the fourth solvent is selected from water, methanol and ethanol; the halogenating agent is selected from bromine, dibromohydantoin, imidazolidinedione, bromosuccinimide, iodosuccinimide and chlorosuccinimide; and the cleavage agent is selected from cysteamine, sodium thiosulfate, ammonium thiocyanate and mercaptopropionic acid.

[0020] Preferably, in step (d), the fourth solvent is water, the halogenating agent is bromosuccinimide, and the cleavage agent is sodium thiosulfate.

[0021] In some embodiments, in step (d), the molar ratio of the sulfurizing agent to compound (IV) ranges from 1:1 to 10:1, or preferably from 3:1 to 5:1.

[0022] In some embodiments, in step (d), the molar ratio of the cleavage reagent to compound (IV) ranges from 1 to 5:1, preferably 2:1 to 3:1; and the reaction temperature ranges from 0 to 100°C, or preferably 70 to 90°C.

[0023] In some embodiments, in step (d), the post-treatment process comprises at least one step selected from filtration, decolorization, electrodialysis, concentration, ion exchange chromatography, and recrystallization in a recrystallization agent.

[0024] Preferably, in step (d), the post-treatment process is recrystallization.

[0025] Examples of recrystallization agents include isopropanol, ethanol, methanol, water, or any combination or mixture thereof.

[0026] Another aspect of the present invention provides an antioxidant composition comprising a mixture of L-ergothioneine and D-ergothioneine.

[0027] In some embodiments, the mixture comprises less than or equal to 100% (eg, 30-80% or 45-55%) enantiomeric equivalents of L-ergothioneine and greater than or equal to 0% (eg, 20-70% or 45-55%) enantiomeric equivalents of D-ergothioneine.

[0028] In some embodiments, the composition is prepared in the form of a nutritional, beverage, cosmetic, or pharmaceutical composition for use in a food, beverage, nutritional, cosmetic, or pharmaceutical product.

[0029] In some embodiments, the composition is administered in the form of capsules, tablets, powders, suspensions, solutions, drops, granules, liquids, syrups, functional foods, beverages, toothpastes, sublingual preparations, foods, food additives, candies, suckers, pastilles, food supplements, and suppositories. DETAILED DESCRIPTION

[0030] The preferred embodiments of the present invention will now be described in detail. Although the present invention will be described in conjunction with the preferred embodiments, it should be understood that they are not intended to limit the present invention to these embodiments. On the contrary, the present invention is intended to cover substitutions, modifications and equivalents, which may be included within the spirit and scope of the present invention as defined in the claims. In addition, in the detailed description of the present invention, many specific details are set forth in order to provide a thorough understanding of the present invention. However, it is apparent to those of ordinary skill in the art that the present invention can be practiced without these specific details. In other cases, well-known methods, procedures, components and other features are not described in detail to avoid unnecessary obscurity of various aspects of the present invention.

[0031] One aspect of the present invention relates to a novel method for the chemical synthesis of thioneine, which produces a high product yield without any racemized product. The method can produce the thioneine of pure optical form (e.g., L-form or D-form) as required, or produce a mixture of any proportion of two forms. Surprisingly, it can directly provide thioneine of high quality standard, and therefore does not require additional purification steps. Ergothioneine can be obtained by the following route, and the reaction scheme is as follows: Reaction scheme

[0032] As shown in the above scheme, it includes four consecutive steps: (a) reacting histidine (compound (I)) with a protecting agent I and a protecting agent II in a first solvent in the presence of a base to obtain compound (II), wherein the histidine is either in a pure optical form (e.g., L-form or D-form) or a mixture of the two forms; (b) reacting compound (II) with an alkylating agent in a second solvent to obtain compound (III); (c) hydrolyzing compound (III) in a third solvent in the presence of an acid to obtain compound (IV); (d) In a fourth solvent, compound (IV) reacts with a halogenating agent, then reacts with a sulfurizing agent selected from L-cysteine, (D,L)-cysteine ​​and D-cysteine, and then reacts with a cleavage agent to obtain ergothioneine (compound (V)).

[0033] Another aspect of the present invention is a composition comprising a mixture of L-ergothioneine and D-ergothioneine or a physiologically acceptable salt thereof, which can be prepared using a chemical synthesis method according to the present invention. The composition has a wide range of applications in treating diseases, beauty applications or nutritional supplements. definition

[0034] As used herein, the term "or" is intended to include "and" and "or." In other words, the term "or" may also be replaced with "and / or."

[0035] As used herein, the singular forms "a", "an" and "the" are intended to include the plural forms as well, unless the context clearly indicates otherwise.

[0036] As used herein, the term "at least" followed by a number is used to indicate the beginning of a range starting with that number.

[0037] As used herein, the term "physiologically acceptable" means generally safe, non-toxic, neither biologically nor otherwise undesirable, and acceptable for pharmaceutical, cosmetic, or food (human or animal) use, particularly food. A "physiologically acceptable salt" of a compound refers to a physiologically acceptable salt as defined above, and which possesses the desired activity (pharmacological, cosmetic, or food) of the parent compound.

[0038] As used herein, the term "tautomer" or "tautomeric form" refers to structural isomers of different energies, which are mutually converted by low energy barriers. The different tautomers of a compound are usually mutually convertible and are present in a solution in an equilibrium state, and their ratios can vary according to the solvent used, temperature or even pH value. Within the framework of the present invention, the ergothioneine obtained by the present invention can exist as a tautomer of its thiol and thione forms.

[0039] The structure of L-ergothioneine (thione-thiol tautomer) is shown below. It exists primarily as the thione form at physiological pH.

[0040] As used herein, the term "optical isomer" or "optical form" refers to any of the various stereoisomeric configurations that may exist for a given compound of the present invention and includes geometric isomers. For example, naturally occurring alanine is a right-handed structure, and the way the groups are arranged around the central carbon atom is called the L-configuration. Another configuration is called the D-configuration.

[0041] As used herein, the term "enantiomer" refers to stereoisomers that are mirror images of each other but are not superimposable. A mixture containing equal amounts of two enantiomers of opposite chirality is called a "racemic mixture." Example

[0042] The synthetic methods described herein are intended to illustrate applicable chemistry through the use of specific examples and are not indicative of the scope of the disclosure.

[0043] All reagents used in the examples were obtained from commercial suppliers without further purification. Example 1. Screening of reaction conditions for obtaining desired products with higher yields

[0044] Step (a): in a first solvent, in the presence of a base, histidine (compound (I)) reacts with a protecting agent I and a protecting agent II to obtain a compound (II), wherein the histidine is either in a pure optical form (e.g., L-form or D-form) or a mixture of the two forms;

[0045] In order to obtain the desired product with a better yield, the reaction conditions of step (a), including solvent, protecting agent and base, were screened. The obtained product was analyzed by high performance liquid chromatography (HPLC), and the results are shown in Table 1.

[0046] The results show that: For the solvent, dichloromethane, chloroform or tetrahydrofuran was used to obtain a yield of more than 90%; for the reagent 1, dimethyldichlorosilane, dichlorodiphenylsilane and trimethylchlorosilane were used to obtain a yield of more than 95%; For reagent 2, the use of triphenylmethane chloride, diphenylmethane chloride, and benzyl bromide gave yields greater than 95%, whereas the use of benzyl chloride gave only about 20% yield; As the base, the use of pyridine, N,N-diisopropylethylamine or triethylamine gave yields higher than 85%. Table 1 Screening of reaction conditions in step (a)

[0047] Step (b): in a second solvent, compound (II) reacts with an alkylating agent to obtain compound (III);

[0048] The reaction conditions of step (b), including the methylating agent, solvent and reaction temperature, were screened to obtain a higher yield of the desired product (i.e., compound (III)). The yield was analyzed by HPLC and the results are listed in Table 2 below.

[0049] The results show that: For the alkylating agent, the use of dimethyl sulfate, methyl iodide or methyl chloride, and dimethyl carbonate gave yields higher than 85%, however, no reaction occurred when trimethyl phosphate (No. 4) was used; As for the solvent, using acetonitrile, methanol, or water gave a yield of more than 80%; however, there was almost no reaction when ethyl acetate was used; Regarding the reaction temperature, a temperature between 20 and 30°C can give a higher yield. However, when the reaction temperature is lowered to 0 to 10°C or raised to 60 to 70°C, the reaction is very slow. Table 2 Screening of reaction conditions in step (b)

[0050] Step (c): hydrolyzing compound (III) in a third solvent in the presence of an acid to obtain compound (IV);

[0051] The reaction conditions of step (c), including solvent, acid and reaction temperature, were screened to obtain the desired product in higher yield. The results were analyzed by HPLC and are listed in Table 3 below.

[0052] The results show that: For the solvent, methanol, acetonitrile, or water was used to give a yield of more than 80%; however, when tetrahydrofuran was used as a solvent, the reaction was very slow; As for the acid, hydrochloric acid, sulfuric acid, trifluoroacetic acid or trifluoromethanesulfonic acid can be used to obtain good yields, especially hydrochloric acid and sulfuric acid, which can obtain yields higher than 95%; Regarding temperature, a temperature of 70-80°C gives better yields than a lower temperature of 50-60°C. Table 3 Screening of reaction conditions in step (c) Embodiment 2. the chemical synthesis method of thioneine

[0053] (a) Under nitrogen protection, 300.0 g of histidine was suspended in 3.0 L of dichloromethane, followed by the addition of 274.5 g of dichlorodimethylsilane, and the solution was then cooled to 15°C. Under stirring, 723.90 g of triethylamine was added dropwise to the solution, with the temperature controlled not to exceed 20°C. After the addition of triethylamine, the reaction mixture was heated at reflux temperature for 4 hours and then cooled to 15°C. After cooling, 592.92 g of triphenylmethane was dissolved in 1.2 L of dichloromethane and then added dropwise to the mixture, with the temperature controlled not to exceed 30°C. After the addition of triphenylmethane, the reaction mixture was heated to reflux for 2 hours and then cooled to 25°C. Next, 3 L of water was added to the reaction mixture and stirred for another 20 minutes. After stirring, the reaction mixture was filtered, and the filtrate was rinsed with 1 L of water and then with 500 mL of dichloromethane. The filtrate was then dried at 60°C to obtain compound (II) with a yield of 99%. The product was used in the next step without further purification. 1 H NMR (400MHz, CD 3 OD-d 6 )δ7.17-7.44(m,16H),6.87(s,1H),3.84(dd,1H),3.17(dd,1H),2.98(dd,1H).

[0054] (b) 120 g of compound (II) from step (a) was added to 1000 ml of methanol, followed by 145.8 g of potassium carbonate, and the solution was then cooled to 30° C. Under stirring, 106.9 g of dimethyl sulfate was then added dropwise. After the addition of dimethyl sulfate, the reaction mixture was heated to 40° C. and maintained for 8 hours. Next, the resulting product was filtered, and the methanol remaining in the filtrate was evaporated at 40° C. to obtain a white solid. The obtained white solid was then suspended in water and stirred at room temperature for 1 to 2 hours. The solid was further filtered and evaporated to dryness at 70 to 80° C. to obtain compound (III) with a yield of 95%. The product was used in the next step without further purification. 1 H NMR (400MHz, CD 3 OD-d 6 )δ7.16-7.44(m,16H),6.91(s,1H),3.89(dd,1H),3.19-3.28(m,11H).

[0055] (c) 50g of compound (III) from step (b) was dissolved in 500ml of water, and then 11.5g of concentrated hydrochloric acid was added at 25°C. The reaction mixture was heated to 70-80°C and kept under stirring for 8 hours. Thin layer chromatography (TLC) was used to monitor the progress of the reaction. At the end of the reaction, the reaction mixture was cooled to 20-30°C. Then, the product was extracted with 500ml of dichloromethane. The dichloromethane extract was then concentrated. The product was further purified by recrystallization from ethanol to obtain compound (IV) with a yield of 98%. The product was used in the next step without further purification. 1 H NMR (400 MHz, D 2 Od 6 )δ7.58(S,1H),6.87(s,1H),3.79(dd,1H),3.09-3.15(m,11H).

[0056] (d) 15g of compound (IV) from step (c) is dissolved in 150ml water, and 15.1g of bromosuccinimide is subsequently added. After stirring for 10 minutes, 46g of L-cysteine ​​is added, stirred for another hour, and then 18.8g of sodium thiosulfate is added. Then, the reaction mixture is heated to 90-100°C and kept for 15 hours. At the end of the reaction, the reaction mixture is cooled and filtered. The pH of the aqueous phase retained is adjusted to neutrality, and then desalinated. The mixture after desalination is further filtered, and the obtained filtrate is evaporated to dryness at 70-80°C. The obtained products are further purified by recrystallization from a mixture of 5ml water and 75ml isopropanol to obtain the desired product, and the yield is 80%. The product is composed of 88% thioneine (V). 1 H NMR (400 MHz, D 2 Od 6 )δ6.72(S,1H),3.83(dd,1H),3.09-3.15(m,11H). Embodiment 3. the chemical synthesis method of thioneine

[0057] (a) 200.0 g of histidine was suspended in 2.0 L of dichloromethane, and then 183 g of dichlorodimethylsilane was added under nitrogen protection, and the solution was then cooled to 15° C. Under stirring, 482.6 g of triethylamine was added dropwise, and the temperature was controlled not to exceed 20° C. After the addition of triethylamine, the reaction mixture was heated to reflux for 6 hours and then cooled to 15° C. After cooling, 592.92 g of diphenylchloromethane was dissolved in 1.2 L of dichloromethane and then added dropwise to the mixture, and the temperature was controlled not to exceed 30° C. After the addition of diphenylchloromethane, the reaction mixture was heated to reflux for 4 hours and then cooled to 25° C. After cooling, 2 L of water was added and stirred for another 20 minutes. The solid was filtered, rinsed with 1 L of water, and then rinsed with 400 mL of dichloromethane. The resulting solid was then dried at 60° C. to obtain an off-white solid of compound (II) with a yield of 94%. The product was used in the next step without further purification. 1 H NMR (400MHz, CD 3 OD-d 6 )δ7.18-7.42(m,6H),6.87(s,1H),3.84(dd,1H),3.17(dd,1H),2.98(dd,1H).

[0058] (b) 150 g of compound (II) from step (a) was added to 1000 ml of methanol, followed by 182.2 g of potassium carbonate, and the solution was cooled to 30° C. Under stirring, 133.6 g of dimethyl sulfate was added dropwise. After the addition of dimethyl sulfate, the reaction mixture was heated to 40° C. and maintained for 8 hours. After 8 hours of reaction, the obtained product was filtered, and the residual methanol in the filtrate was evaporated at 40° C. to obtain a white solid. The obtained white solid was then suspended in water and stirred at room temperature for 1 to 2 hours. After stirring, the solid was filtered and evaporated to dryness at 70 to 80° C. to obtain compound (III) with a yield of 85%. The product was used in the next step without further purification. 1 H NMR (400MHz, CD 3 OD-d 6 )δ7.16-7.44(m,11H),6.91(s,1H),3.89(dd,1H),3.19-3.28(m,11H).

[0059] (c) 50 g of compound (III) from step (b) was added to 500 ml of water, followed by the addition of 50 g of concentrated hydrochloric acid at 25°C. After the addition of hydrochloric acid, the reaction mixture was heated to 70-80°C and kept under stirring for 12 hours. TLC was used to monitor the progress of the reaction. At the end of the reaction, the reaction mixture was cooled to 20-30°C. The product was then extracted with 500 ml of dichloromethane. The dichloromethane extract was concentrated. The product was further purified by recrystallization from ethanol to obtain compound (IV) with a yield of 96.3%. 1 H NMR (400 MHz, D 2 Od 6 )δ7.58(S,1H),6.87(s,1H),3.79(dd,1H),3.09-3.15(m,11H).

[0060] (d) 15g of compound (IV) from step (c) is added to 150ml water, followed by 6.3g of concentrated sulfuric acid and 15.1g of bromosuccinimide, and the solution is stirred for 10 minutes. After stirring for 10 minutes, L-cysteine ​​is added and stirred for another hour, followed by 18.8g of sodium thiosulfate. Then, the reaction mixture is heated to 90-100°C and kept for 15 hours. At the end of the reaction, the reaction mixture is cooled and filtered. The pH of the retained aqueous phase is adjusted to neutral, then desalted. The mixture after desalination is further filtered, and the obtained filtrate is evaporated to dryness at 70-80°C. The obtained product is further purified by recrystallization from a combination of 5ml water and 65ml isopropanol to obtain the desired product, with a yield of 75%. The desired product consists of 94% ergothioneine (V). 1 H NMR (400 MHz, D 2 Od 6 )δ6.72(S,1H),δ6.86(S,1H),3.83(dd,1H),3.09-3.15(m,11H). Embodiment 4 The chemical synthesis method of thioneine

[0061] (a) 200.0 g of histidine was suspended in 2.0 L of dichloromethane, and then 183 g of dichlorodimethylsilane was added under nitrogen protection, and the solution was then cooled to 15° C. Under stirring, 482.6 g of triethylamine was then added dropwise, with the temperature controlled not to exceed 20° C. After the addition of triethylamine, the reaction mixture was heated to reflux for 6 hours and then cooled to 15° C. After cooling, 242.5 g of benzyl bromide was added dropwise to 1.2 L of dichloromethane, with the temperature controlled not to exceed 30° C. After the addition of benzyl bromide, the reaction mixture was heated to reflux for 4 hours and then cooled to 25° C. Then 2 L of water was added and stirred for another 20 minutes. After stirring, the resulting product was filtered, then rinsed with 1 L of water, and then rinsed with 400 mL of dichloromethane. The filtrate was dried at 60° C. to obtain an off-white solid of compound (II) with a yield of 94%. 1 H NMR (400MHz, CD 3 OD-d 6 )δ7.18-7.42(m,6H),6.87(s,1H),6.45(s,2H),3.84(dd,1H),3.17(dd,1H),2.98(dd,1H).

[0062] (b) 100 g of compound (II) from step (a) was added to 1000 ml of methanol, followed by 135.2 g of potassium carbonate, and the solution was cooled to 30° C. Under stirring, 121.6 g of dimethyl sulfate was added dropwise. After the addition of dimethyl sulfate, the reaction mixture was heated to 40° C. and maintained for 8 hours. At the end of the reaction, the product was filtered and the residual methanol in the filtrate was evaporated at 40° C. to obtain a white solid. The white solid was then suspended in water and stirred at room temperature for 1 to 2 hours. The solid was further filtered and heated to dryness at 70 to 80° C. to obtain compound (III) with a yield of 81%. 1 H NMR (400MHz, CD 3 OD-d 6 )δ7.12-7.2(m,6H),6.91(s,1H),6.45(s,2H),3.89(dd,1H),3.19-3.28(m,11H).

[0063] (c) 50 g of compound (III) from step (b) was added to 500 ml of water, followed by 25.8 g of trifluoroacetic acid at 25° C. The reaction mixture was heated to 70-80° C. and kept under stirring for 12 hours. TLC was used to monitor the progress of the reaction. At the end of the reaction, the mixture was cooled to 20-30° C. The product was then extracted with dichloromethane. The dichloromethane extract was then concentrated. The product was further purified by recrystallization from ethanol to obtain compound (IV) with a yield of 97%. 1 H NMR (400 MHz, D 2 Od 6 )δ7.58(S,1H),6.87(s,1H),3.79(dd,1H),3.09-3.15(m,11H).

[0064] (d) 20g of compound (IV) from step (c) is added in 200ml water, followed by 20g of bromosuccinimide. After stirring for 0.5 hour, L-cysteine ​​is added and stirred for another 1 hour, then 11.3g of ammonium thiocyanate is added. After pH is adjusted to 12, the reaction mixture is heated to 80-90°C and kept for 15 hours. At the end of the reaction, the reaction mixture is cooled and filtered. The pH of the retained aqueous phase is adjusted to 6-8, and then the mixture is desalted. The mixture after desalination is further filtered, and the obtained filtrate is evaporated to dryness at 70-80°C. The obtained product is further purified by recrystallization from a combination of 5ml water and 60ml isopropanol to obtain the desired product, with a yield of 68%. The desired product consists of 96% ergothioneine (V). 1 H NMR (400 MHz, D 2 Od 6 )δ6.72(S,1H),3.83(dd,1H),3.09-3.15(m,11H). Embodiment 5. the chemical synthesis method of thioneine

[0065] (a) 300.0 g of histidine was suspended in 3.0 L of dichloromethane, and then 274.5 g of dichlorodimethylsilane was added under nitrogen protection, and then the solution was cooled to 15 ° C. Under stirring, 723.90 g of triethylamine was added dropwise, and the temperature was controlled not to exceed 20 ° C. After adding triethylamine, the reaction temperature was heated to reflux for 4 hours and then cooled to 15 ° C. After cooling, 592.92 g of triphenylmethane was added dropwise to 1.2 L of dichloromethane, and the temperature was controlled not to exceed 30 ° C. After adding triphenylmethane, the reaction mixture was heated to reflux for 2 hours and then cooled to 25 ° C. After cooling, 3 L of water was added and stirred for 20 minutes. After stirring, the obtained product was filtered, then rinsed with 1 L of water, and then rinsed with 500 mL of dichloromethane. The filtrate was dried at 60 ° C to obtain an off-white solid compound (II) with a yield of 95%. The product was used in the next step without further purification. 1 H NMR (400MHz, CD 3 OD-d 6)δ7.17-7.44(m,16H),6.87(s,1H),3.84(dd,1H),3.17(dd,1H),2.98(dd,1H).

[0066] (b) 120 g of compound (II) was added to 1000 ml of methanol, followed by 145.8 g of potassium carbonate, and the solution was then cooled to 30°C. After cooling, 150 g of iodomethane was added dropwise. After addition, the reaction mixture was heated to 40°C and maintained for 12 hours. At the end of the reaction, the reaction mixture was filtered and the remaining methanol in the filtrate was dried at 40°C to obtain a white solid. The white solid was added to water and stirred at room temperature for 1 to 2 hours. The solid was further filtered and dried at 70 to 80°C to obtain compound (III) with a yield of 87%. The product was used in the next step without further purification. 1 H NMR (400MHz, CD 3 OD-d 6 )δ7.16-7.44(m,16H),6.91(s,1H),3.89(dd,1H),3.19-3.28(m,11H).

[0067] (c) 50 g of compound (III) from step (b) was added to 500 ml of water, followed by 11.5 g of concentrated hydrochloric acid at 25 ° C. After the addition of hydrochloric acid, the reaction mixture was heated to 70-80 ° C and kept under stirring for 8 hours. TLC was used to monitor the progress of the reaction. At the end of the reaction, the reaction mixture was cooled to 20-30 ° C. Then, the product was extracted with 500 ml of dichloromethane. The dichloromethane extract was then concentrated. The product was further purified by recrystallization from ethanol to obtain compound (IV) with a yield of 98%. The product was used in the next step without further purification. 1 H NMR (400 MHz, D 2 Od 6 )δ7.58(S,1H),6.87(s,1H),3.79(dd,1H),3.09-3.15(m,11H).

[0068] (d) 15g of compound (IV) from step (c) is added to 150ml water, followed by 12g of concentrated hydrochloric acid. After adding 7.8g of hydrochloric acid, 10.9g of dibromohydantoin is added and stirred for 20 minutes. After stirring, L-cysteine ​​is added and stirred for another 1 hour, followed by 18.8g of sodium thiosulfate. Then, the reaction mixture is heated to 90-100°C and kept for 15 hours. At the end of the reaction, the reaction mixture is cooled and filtered. The pH of the aqueous phase retained is adjusted to neutral, and the mixture is then desalted. The mixture after desalination is further filtered, and the obtained filtrate is evaporated to dryness at 70-80°C. The obtained product is further purified by recrystallization from a combination of 10ml water and 50ml of isopropanol to obtain the desired product, with a yield of 69%. The desired product consists of 99.8% ergothioneine (V). 1 H NMR (400 MHz, D 2 Od 6 )δ6.72(S,1H),3.83(dd,1H),3.09-3.15(m,11H). Embodiment 6. the chemical synthesis method of ergothioneine

[0069] (a) 300.0 g of histidine was suspended in 3.0 L of dichloromethane, and then 274.5 g of dichlorodimethylsilane was added under nitrogen protection, and the solution was then cooled to 15°C. After cooling, 723.90 g of triethylamine was added dropwise, and the temperature was controlled not to exceed 20°C. After the addition of triethylamine, the reaction mixture was heated to reflux for 4 hours and then cooled to 15°C. After cooling, 592.92 g of triphenylmethane was added to 1.2 L of dichloromethane and then added dropwise to the solution, and the temperature was controlled not to exceed 30°C. After addition, the reaction mixture was heated to reflux for 2 hours and then cooled to 25°C. After cooling, 3 L of water was added to the mixture and stirred for 20 minutes. After stirring for 20 minutes, the resulting product was filtered, rinsed with 1 L of water, and then rinsed with 500 mL of dichloromethane. The filtrate was dried at 60°C to obtain an off-white solid of compound (II) with a yield of 95%. The product was used in the next step without further purification. 1 H NMR (400MHz, CD 3 OD-d 6 )δ7.17-7.44(m,16H),6.87(s,1H),3.84(dd,1H),3.17(dd,1H),2.98(dd,1H).

[0070] (b) 120 g of compound (II) from step (a) was added to 1000 ml of methanol, followed by 145.8 g of potassium carbonate, and the solution was then cooled to 30° C. Under stirring, 150 g of methyl iodide was added dropwise. After the addition of methyl iodide, the reaction temperature was heated to 40° C. and maintained for 12 hours. At the end of the reaction, the product produced was filtered and the remaining methanol in the filtrate was dried at 40° C. to obtain a white solid. The solid was suspended in water and stirred at room temperature for 1 to 2 hours. The solid was further filtered and dried at 70 to 80° C. to obtain compound (III) with a yield of 87%. The product was used in the next step without further purification. 1 H NMR (400MHz, CD 3 OD-d 6 )δ7.16-7.44(m,16H),6.91(s,1H),3.89(dd,1H),3.19-3.28(m,11H).

[0071] (c) 50 g of compound (III) was added to 500 ml of water, followed by concentrated hydrochloric acid at 25 ° C. The reaction mixture was heated to 70-80 ° C and kept under stirring for 8 hours. TLC was used to monitor the progress of the reaction. At the end of the reaction, the reaction mixture was cooled to 20-30 ° C. Then, the product was extracted with 500 ml of dichloromethane. The dichloromethane extract was then concentrated. The product was further purified by recrystallization from ethanol to obtain compound (IV) with a yield of 98%. The product was used in the next step without further purification. 1 H NMR (400 MHz, D 2 Od 6 )δ7.58(S,1H),6.87(s,1H),3.79(dd,1H),3.09-3.15(m,11H).

[0072] (d) 15g compound (IV) is added in 150ml water, then 15.6g concentrated hydrochloric acid and 10.9g dibromohydantoin are added under stirring. After stirring for 20 minutes, D-cysteine ​​is added and stirred for another 1 hour, then 18.8g sodium thiosulfate is added. After stirring, the reaction mixture is heated to 90-100 ℃ and kept for 15 hours. At the end of the reaction, the reaction mixture is cooled and filtered. The pH of the aqueous phase retained is adjusted to neutral, and the mixture is then desalted. The mixture after desalination is further filtered, and the obtained filtrate is evaporated to dryness at 70-80 ℃. The obtained products are further purified by recrystallization from the combination of 5ml water and 75ml isopropanol to obtain the desired product. The desired product is composed of 88% ergothioneine (compound (V)). 1 H NMR (400 MHz, D2 Od 6 )δ6.72(S,1H),3.83(dd,1H),3.09-3.15(m,11H).

[0073] Although specific embodiments and examples of the present invention have been described herein, it will be appreciated by those skilled in the art that any modifications and variations may be made without departing from the principles of the present invention. The above embodiments and descriptions do not limit the scope of the present invention. Any combination of embodiments of the present invention, as well as any obvious extensions or the like, are within the scope of the present invention. In addition, the present invention encompasses any arrangement intended to achieve the same purpose, as well as all such variations and modifications within the scope of the appended claims.

[0074] Unless expressly stated otherwise, all features disclosed in this specification (including any accompanying claims, abstract and drawings) may be replaced by alternative features serving the same, equivalent or similar purpose. Therefore, unless expressly stated otherwise, each feature disclosed is an example of a series of equivalent or similar features.

[0075] It should be understood that although the present invention has been described in conjunction with the detailed description of the present invention and the accompanying drawings, the foregoing description and the accompanying drawings are intended only to illustrate and not to limit the scope of the present invention, which is defined by the scope of the appended claims. Other aspects, advantages and modifications are within the scope of the appended claims. All publications cited herein are incorporated by reference in their entirety.

Claims

1. A method for synthesizing different optical isomers of ergothioneine or its physiologically acceptable salt, It is characterized in that The method comprises the following consecutive steps: (a) in a first solvent, in the presence of a base, histidine (compound (I)) and a protecting agent I and a protecting Reagent II is reacted to obtain compound (II), wherein the histidine is in L-form, D-form, or L- and D- Mixtures in any proportions; (b) reacting the compound (II) with an alkylating agent in a second solvent to obtain a compound (III); (c) hydrolyzing the compound (III) in a third solvent in the presence of an acid to obtain a compound (IV); (d) in a fourth solvent, the compound (IV) is reacted with a halogenating agent and then with a The sulfidation reagents for amino acids, (D,L)-cysteine ​​and D-cysteine ​​are then reacted with the cleavage reagents. The method can obtain ergothioneine (compound (V)) after a post-treatment process; wherein the obtained ergothioneine is in L-form, D-form or a mixture of L- and D-forms in any ratio.

2. The method according to claim 1, It is characterized in that The compound (II) has the formula II structure, Where R is 3. The method according to claim 1, It is characterized in that The compound (III) has the formula III The structure, Where R is 4. The method according to claim 1, It is characterized in that The compound (IV) has a structure of formula IV, 5. The method according to claim 1, It is characterized in that The compound (V) has a structure of formula V, 6. The method according to claim 1, It is characterized in that In step (a), the protecting agent 1 is selected from dimethyldichlorosilane, trimethylchlorosilane and dichlorodiphenylsilane; the protecting agent 2 is selected from triphenylmethane chloride, chlorodiphenylmethane and benzyl bromide; the first solvent is selected from dichloromethane, tetrahydrofuran and chloroform; and the base is selected from pyridine, N,N-diisopropylethylamine and triethylamine.

7. The method according to claim 6, It is characterized in that The protecting agent 1 is dimethyldichlorosilane, the protecting agent 2 is triphenylmethane, the first solvent is dichloromethane, and the base is triethylamine or pyridine.

8. The method according to claim 1, It is characterized in that In step (a), the molar ratio of the base to the compound (I) is in the range of 1:1 to 3:1; the molar ratio of the protecting agent 1 to the compound (I) is in the range of 1:1 to 3:1; the molar ratio of the protecting agent 2 to the compound (I) is in the range of 1:1 to 3:1; and the reaction temperature is in the range of 0-80°C or 10 to 40°C.

9. The method according to claim 1, It is characterized in that In step (b), the alkylating agent is selected from dimethyl sulfate, methyl iodide, methyl bromide or methyl chloride; and the second solvent is selected from acetonitrile, methanol, ethanol or water.

10. The method according to claim 9, It is characterized in that The alkylating agent is dimethyl sulfate, and the second solvent is methanol.

11. The method according to claim 1, It is characterized in that In step (b), the molar ratio of the alkylating agent to the compound (II) is in the range of 1:1 to 3:1; and the reaction temperature is in the range of 20 to 100°C or 20 to 30°C.

12. The method according to claim 1, It is characterized in that In step (c), the third solvent is selected from acetonitrile, methanol, ethanol or water; the acid is selected from hydrochloric acid, sulfuric acid, trifluoroacetic acid and trifluoromethanesulfonic acid.

13. The method according to claim 12, It is characterized in that The third solvent is water, and the acid is hydrochloric acid.

14. The method according to claim 1, It is characterized in that In step (c), the molar ratio of the acid to compound (III) is in the range of 1:1 to 10:1 or 2:1 to 5:1; and the reaction temperature is in the range of 20 to 80°C or 70 to 80°C.

15. The method according to claim 1, It is characterized in that In step (d), the fourth solvent is selected from water, methanol and ethanol; the halogenating agent is selected from bromine, dibromohydantoin, imidazolidinedione, bromosuccinimide, iodosuccinimide, chlorosuccinimide; and the cleavage agent is selected from cysteamine, sodium thiosulfate, ammonium thiocyanate and mercaptopropionic acid.

16. The method according to claim 15, It is characterized in that The fourth solvent is water, the halogenating agent is bromosuccinimide, and the cleaving agent is sodium thiosulfate.

17. The method according to claim 1, It is characterized in that In step (d), the molar ratio of the sulfiding agent to the compound (IV) is in the range of 1:1 to 10:1 or 3:1 to 5:

1.

18. The method according to claim 1, It is characterized in that In step (d), the molar ratio of the cleavage reagent to the compound (IV) ranges from 1:1 to 5:1 or 2:1 to 3:1; and the reaction temperature is selected from 0 to 100°C or 70 to 90°C.

19. The method according to claim 1, It is characterized in that In step (d), the post-treatment process comprises at least one step selected from filtration, decolorization, electrodialysis, concentration, ion exchange chromatography and recrystallization in a recrystallization agent.

20. The method according to claim 19, It is characterized in that The post-treatment process is recrystallization.

21. The method according to claim 19, It is characterized in that The recrystallization reagent is at least one reagent selected from isopropanol, ethanol, methanol and water.

22. An antioxidant composition, It is characterized in that The antioxidant composition comprises L-ergothioneine or D-ergothioneine, or a mixture of L-ergothioneine and D-ergothioneine.

Citation Information

Cited By

  • Synthesis method of ergothioneine

    CN116102502A

  • Application and preparation method of liquid mask care silicone rubber

    CN120420240A